Influence of CPAP treatment on airway and systemic inflammation in OSAS patients.
about
Inflammatory Role of ROS-Sensitive AMP-Activated Protein Kinase in the Hypersensitivity of Lung Vagal C Fibers Induced by Intermittent Hypoxia in RatsTumor necrosis factor alpha is a promising circulating biomarker for the development of obstructive sleep apnea syndrome: a meta-analysis.Association between systemic inflammation and obstructive sleep apnea in men with or at risk for HIV infectionMaking sense of oxidative stress in obstructive sleep apnea: mediator or distracter?Effect of Continuous Positive Airway Pressure on Airway Inflammation and Oxidative Stress in Patients with Obstructive Sleep Apnea.Management and Risk Reduction of Rheumatoid Arthritis in Individuals with Obstructive Sleep Apnea: A Nationwide Population-Based Study in Taiwan.What can blood biomarkers tell us about cardiovascular risk in obstructive sleep apnea?Asthma and Obstructive Sleep Apnea.Exhaled breath analysis in obstructive sleep apnea.Increased Exhaled 8-Isoprostane and Interleukin-6 in Patients with Helicobacter pylori Infection.Evaluation of MIh Scoring System in Diagnosis of Obstructive Sleep Apnea Syndrome.Complete blood count alterations after six months of continuous positive airway pressure treatment in patients with severe obstructive sleep apnea.Serum levels of gamma-glutamyl transferase are associated with cardiovascular disease in obstructive sleep apnea syndrome.Inflammatory and oxidative stress‑associated factors in chronic intermittent hypoxia in Chinese patients, rats, lymphocytes and endotheliocytes.Effect of modern surgical treatment on the inflammatory/anti-inflammatory balance in patients with obstructive sleep apnoea.Snoring as a Determinant Factor of Oxidative Stress in the Airway of Patients with Obstructive Sleep Apnea.Roles of interleukin (IL)-6 gene polymorphisms, serum IL-6 levels, and treatment in obstructive sleep apnea: a meta-analysis.Strategies to decrease oxidative stress biomarker levels in human medical conditions: A meta-analysis on 8-iso-prostaglandin F2α.
P2860
Q28828765-404CEE49-C39D-4FAE-B2A3-1D16C90CD27BQ33689147-1DC6441D-E739-4F20-B6A4-F723E66B80B9Q34036498-C7173BD7-EC34-4090-85C7-C856AAA59B6EQ36490066-7A6461EA-97B7-4F9E-97A8-5625B9BA3162Q37092866-C9FF6A93-A560-482D-A0C3-0EABF502DD0FQ37251075-1EE96A8F-552F-4552-9838-528255B63B95Q38365338-28D83941-0E53-4F91-9DB3-733634160F16Q38611214-A06A9835-210F-4139-974C-FE51D1E12ABCQ39352471-8E3B2EB7-30AE-4207-9DA0-5892426AF14FQ40721806-12FCB09D-41DB-45D6-B795-0C5620395AC7Q42705460-54A1B1AE-F0AD-48A2-911E-B498C2EBB9EDQ42743567-320A91AA-5174-4C5C-BA79-E99F1C17B7EDQ45344017-5F1B2818-AF65-4B32-9840-FBC2D8783358Q47689143-DA61BC56-8CBC-4EF5-92AC-F924F9ABC097Q47728243-CA6078C4-EE03-4D4D-92EA-D6FB579D6C23Q47870891-2323090F-3FA1-4E27-8589-EDF44DB52B4AQ47918714-09F03560-BAA4-4B5E-B9F3-BA1ACE517C3FQ55279804-C1C8193E-FD5F-49F7-A646-6805D360B9E5
P2860
Influence of CPAP treatment on airway and systemic inflammation in OSAS patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Influence of CPAP treatment on airway and systemic inflammation in OSAS patients.
@en
Influence of CPAP treatment on airway and systemic inflammation in OSAS patients.
@nl
type
label
Influence of CPAP treatment on airway and systemic inflammation in OSAS patients.
@en
Influence of CPAP treatment on airway and systemic inflammation in OSAS patients.
@nl
prefLabel
Influence of CPAP treatment on airway and systemic inflammation in OSAS patients.
@en
Influence of CPAP treatment on airway and systemic inflammation in OSAS patients.
@nl
P2093
P2860
P1433
P1476
Influence of CPAP treatment on airway and systemic inflammation in OSAS patients.
@en
P2093
Bulent Bozkurt
Duygu Özol
Ferah Armutçu
Harun Karamanlı
K Serife Ugur
Ramazan Yigitoglu
Zeki Yıldırım
P2860
P2888
P304
P356
10.1007/S11325-012-0761-8
P577
2012-09-04T00:00:00Z